questionsmedicales.fr
Thérapeutique
Thérapie respiratoire
Oxygénothérapie
Oxygénation hyperbare
Oxygénation hyperbare : Questions médicales fréquentes
Termes MeSH sélectionnés :
Randomized Controlled Trials as Topic
Diagnostic
5
Maladie de décompression
Évaluation clinique
Imagerie médicale
Évaluation pré-thérapeutique
Symptômes
Troubles neurologiques
Évaluation thérapeutique
Suivi médical
Critères d'admission
Contre-indications
Symptômes
5
Symptômes
Troubles de la vision
Intoxication à l'oxygène
Convulsions
Embolie gazeuse
Troubles respiratoires
Réaction allergique
Éruptions cutanées
Prévention
5
Précautions
Antécédents médicaux
Intoxication à l'oxygène
Protocoles de traitement
Préparation psychologique
Information
Traitements
5
Maladie de décompression
Infections
Chambre hyperbare
Thérapie
Durée de traitement
Thérapie
Effets secondaires
Nausées
Médecine hyperbare
Professionnels de santé
Complications
5
Complications
Lésions pulmonaires
Embolie gazeuse
Intervention médicale
Barotraumatismes
Réactions allergiques
Complications graves
Troubles neurologiques
Facteurs de risque
5
Facteurs de risque
Plongée
Intoxication à l'oxygène
Plongeurs
Antécédents médicaux
Troubles respiratoires
Médicaments
Déshydratation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Oxygénation hyperbare : Questions médicales les plus fréquentes",
"headline": "Oxygénation hyperbare : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Oxygénation hyperbare : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-26",
"dateModified": "2025-04-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Oxygénation hyperbare"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxygénothérapie",
"url": "https://questionsmedicales.fr/mesh/D010102",
"about": {
"@type": "MedicalCondition",
"name": "Oxygénothérapie",
"code": {
"@type": "MedicalCode",
"code": "D010102",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.880.690"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Oxygénation hyperbare",
"alternateName": "Hyperbaric Oxygenation",
"code": {
"@type": "MedicalCode",
"code": "D006931",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Richard E Moon",
"url": "https://questionsmedicales.fr/author/Richard%20E%20Moon",
"affiliation": {
"@type": "Organization",
"name": "Departments of Anesthesiology and Medicine, Center for Hyperbaric Medicine and Environmental Physiology, Duke University, North Carolina U.S."
}
},
{
"@type": "Person",
"name": "John P Kirby",
"url": "https://questionsmedicales.fr/author/John%20P%20Kirby",
"affiliation": {
"@type": "Organization",
"name": "John P. Kirby MD, FACS, is the Director of Wound Healing Programs, Associate Professor of Surgery, Section of Acute and Critical Care Surgery, at Washington University School of Medicine, Barnes-Jewish Hospital, in St. Louis, Missouri."
}
},
{
"@type": "Person",
"name": "Stephen R Thom",
"url": "https://questionsmedicales.fr/author/Stephen%20R%20Thom",
"affiliation": {
"@type": "Organization",
"name": "Emergency Medicine, University of Maryland, Baltimore, MD, USA."
}
},
{
"@type": "Person",
"name": "Michael H Bennett",
"url": "https://questionsmedicales.fr/author/Michael%20H%20Bennett",
"affiliation": {
"@type": "Organization",
"name": "Department of Diving and Hyperbaric Medicine, Prince of Wales Hospital and University of New South Wales, Sydney, New South Wales, Australia."
}
},
{
"@type": "Person",
"name": "Simon J Mitchell",
"url": "https://questionsmedicales.fr/author/Simon%20J%20Mitchell",
"affiliation": {
"@type": "Organization",
"name": "Department of Anaesthesiology, University of Auckland Faculty of Medicine, Auckland, New Zealand."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Topical diquafosol versus hyaluronic acid for the treatment of dry eye disease: a meta-analysis of randomized controlled trials.",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37162564",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00417-023-06083-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.",
"datePublished": "2024-07-16",
"url": "https://questionsmedicales.fr/article/39014498",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-024-08334-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Design and Methodological Issues of Within-Person (Split-Body) Randomized Controlled Trials Evaluating a Topical Treatment: A Systematic Review.",
"datePublished": "2023-03-29",
"url": "https://questionsmedicales.fr/article/36990057",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000530149"
}
},
{
"@type": "ScholarlyArticle",
"name": "Laser and light therapy combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials.",
"datePublished": "2023-02-17",
"url": "https://questionsmedicales.fr/article/36800063",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10103-023-03734-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nd:YAG/Er:YAG dual laser vs. topical steroid to treat vulvar lichen sclerosus: study protocol of a randomized controlled trial.",
"datePublished": "2023-05-05",
"url": "https://questionsmedicales.fr/article/37145134",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00404-023-07055-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Thérapie respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012138"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxygénothérapie",
"item": "https://questionsmedicales.fr/mesh/D010102"
},
{
"@type": "ListItem",
"position": 5,
"name": "Oxygénation hyperbare",
"item": "https://questionsmedicales.fr/mesh/D006931"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Oxygénation hyperbare - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Oxygénation hyperbare",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Oxygénation hyperbare",
"description": "Comment diagnostiquer une décompression ?\nQuels tests pour l'oxygénation hyperbare ?\nQuels symptômes indiquent un traitement ?\nComment évaluer l'efficacité du traitement ?\nQuels critères pour l'admission en chambre hyperbare ?",
"url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Oxygénation hyperbare",
"description": "Quels sont les symptômes de l'oxygénation hyperbare ?\nComment se manifeste l'intoxication à l'oxygène ?\nQuels signes d'une embolie gazeuse ?\nQuels symptômes après une séance d'oxygénation ?\nComment reconnaître une réaction allergique ?",
"url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Oxygénation hyperbare",
"description": "Comment prévenir la maladie de décompression ?\nQuelles précautions avant une séance ?\nComment éviter l'intoxication à l'oxygène ?\nQuelles sont les recommandations post-traitement ?\nComment se préparer psychologiquement ?",
"url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Oxygénation hyperbare",
"description": "Quelles conditions traitent l'oxygénation hyperbare ?\nComment se déroule une séance d'oxygénation ?\nQuelle est la durée d'une séance ?\nY a-t-il des effets secondaires ?\nQui peut administrer ce traitement ?",
"url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Oxygénation hyperbare",
"description": "Quelles complications peuvent survenir ?\nComment gérer une embolie gazeuse ?\nQuels risques liés à l'oxygénation hyperbare ?\nComment prévenir les infections en chambre ?\nQuels signes d'une complication grave ?",
"url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Oxygénation hyperbare",
"description": "Quels sont les facteurs de risque de décompression ?\nQui est à risque d'intoxication à l'oxygène ?\nQuels antécédents augmentent les risques ?\nComment l'âge influence-t-il les risques ?\nQuels médicaments augmentent les risques ?",
"url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une décompression ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic de décompression se fait par l'évaluation des symptômes et des antécédents d'immersion."
}
},
{
"@type": "Question",
"name": "Quels tests pour l'oxygénation hyperbare ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie et des évaluations cliniques sont utilisés pour déterminer l'indication."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un traitement ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs articulaires, des troubles neurologiques ou des brûlures peuvent indiquer un traitement."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité du traitement ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par l'amélioration des symptômes et des tests de suivi après traitement."
}
},
{
"@type": "Question",
"name": "Quels critères pour l'admission en chambre hyperbare ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent des conditions médicales spécifiques et l'absence de contre-indications."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'oxygénation hyperbare ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des douleurs, des vertiges, et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'intoxication à l'oxygène ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'intoxication à l'oxygène se manifeste par des convulsions, des nausées et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Quels signes d'une embolie gazeuse ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs thoraciques, des difficultés respiratoires et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes après une séance d'oxygénation ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Après une séance, des sensations de fatigue ou de légers maux de tête peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une réaction allergique peut se manifester par des éruptions cutanées, des démangeaisons ou un gonflement."
}
},
{
"@type": "Question",
"name": "Comment prévenir la maladie de décompression ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut une ascension lente après la plongée et des pauses de sécurité."
}
},
{
"@type": "Question",
"name": "Quelles précautions avant une séance ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez de fumer, de consommer de l'alcool et informez le médecin de vos antécédents médicaux."
}
},
{
"@type": "Question",
"name": "Comment éviter l'intoxication à l'oxygène ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pour éviter l'intoxication, respectez les protocoles de traitement et les durées recommandées."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations post-traitement ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Après traitement, reposez-vous et évitez les activités physiques intenses pendant 24 heures."
}
},
{
"@type": "Question",
"name": "Comment se préparer psychologiquement ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Préparez-vous en vous informant sur le traitement et en discutant avec des professionnels."
}
},
{
"@type": "Question",
"name": "Quelles conditions traitent l'oxygénation hyperbare ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle traite des conditions comme la maladie de décompression, les infections et les brûlures."
}
},
{
"@type": "Question",
"name": "Comment se déroule une séance d'oxygénation ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une séance se déroule dans une chambre pressurisée où le patient respire de l'oxygène pur."
}
},
{
"@type": "Question",
"name": "Quelle est la durée d'une séance ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une séance dure généralement entre 60 et 120 minutes, selon la condition traitée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des douleurs aux oreilles, des nausées ou des troubles visuels."
}
},
{
"@type": "Question",
"name": "Qui peut administrer ce traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement doit être administré par des professionnels de santé formés en médecine hyperbare."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions pulmonaires, des convulsions et des infections."
}
},
{
"@type": "Question",
"name": "Comment gérer une embolie gazeuse ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une embolie gazeuse nécessite une intervention rapide, souvent avec une oxygénation hyperbare."
}
},
{
"@type": "Question",
"name": "Quels risques liés à l'oxygénation hyperbare ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des barotraumatismes, des troubles de la vision et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections en chambre ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pour prévenir les infections, maintenez une bonne hygiène et suivez les protocoles de désinfection."
}
},
{
"@type": "Question",
"name": "Quels signes d'une complication grave ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des douleurs thoraciques intenses ou des troubles neurologiques nécessitent une attention immédiate."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de décompression ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la profondeur de plongée, la durée et l'absence de pauses de sécurité."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'intoxication à l'oxygène ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les plongeurs et les patients recevant une oxygénation hyperbare à haute pression sont à risque."
}
},
{
"@type": "Question",
"name": "Quels antécédents augmentent les risques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents de troubles respiratoires ou neurologiques peuvent augmenter les risques."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il les risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées peuvent avoir un risque accru de complications en raison de la fragilité des tissus."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent les risques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments, comme les diurétiques, peuvent augmenter le risque de déshydratation et de complications."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 20/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Departments of Anesthesiology and Medicine, Center for Hyperbaric Medicine and Environmental Physiology, Duke University, North Carolina U.S.
Publications dans "Oxygénation hyperbare" :
3 publications dans cette catégorie
Affiliations :
John P. Kirby MD, FACS, is the Director of Wound Healing Programs, Associate Professor of Surgery, Section of Acute and Critical Care Surgery, at Washington University School of Medicine, Barnes-Jewish Hospital, in St. Louis, Missouri.
Publications dans "Oxygénation hyperbare" :
3 publications dans cette catégorie
Affiliations :
Emergency Medicine, University of Maryland, Baltimore, MD, USA.
Publications dans "Oxygénation hyperbare" :
2 publications dans cette catégorie
Affiliations :
Department of Diving and Hyperbaric Medicine, Prince of Wales Hospital and University of New South Wales, Sydney, New South Wales, Australia.
Publications dans "Oxygénation hyperbare" :
2 publications dans cette catégorie
Affiliations :
Department of Anaesthesiology, University of Auckland Faculty of Medicine, Auckland, New Zealand.
Publications dans "Oxygénation hyperbare" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Henrik Harpestrengs Vej 4A, 2100, Copenhagen, Denmark.
Publications dans "Oxygénation hyperbare" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Denmark.
Publications dans "Oxygénation hyperbare" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital and Department of Immunology and Microbiology (ISIM), University of Copenhagen, Denmark.
Publications dans "Oxygénation hyperbare" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Microbiology, Zealand University Hospital, Denmark.
Publications dans "Oxygénation hyperbare" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet and Department of Immunology and Microbiology (ISIM), University of Copenhagen, Denmark.
Publications dans "Oxygénation hyperbare" :
2 publications dans cette catégorie
Affiliations :
Adelaide Medical School, The University of Adelaide, Adelaide, Australia.
Publications dans "Oxygénation hyperbare" :
2 publications dans cette catégorie
Affiliations :
Hyperbaric Unit, Mater Dei Hospital, Msida, Malta.
Publications dans "Oxygénation hyperbare" :
1 publication dans cette catégorie
Affiliations :
ole.hyldegaard@regionh.dk.
Publications dans "Oxygénation hyperbare" :
1 publication dans cette catégorie
Publications dans "Oxygénation hyperbare" :
1 publication dans cette catégorie
Affiliations :
University of North Texas Health Science Center, Department of Internal Medicine, Fort Worth, Texas U.S.
Publications dans "Oxygénation hyperbare" :
1 publication dans cette catégorie
Affiliations :
Department of Dermatology, San Antonio Uniformed Services Health Education Consortium, Joint Base San Antonio-Lackland, Texas, USA.
Publications dans "Oxygénation hyperbare" :
1 publication dans cette catégorie
Affiliations :
Department of Dermatology, San Antonio Uniformed Services Health Education Consortium, Joint Base San Antonio-Lackland, Texas, USA.
Publications dans "Oxygénation hyperbare" :
1 publication dans cette catégorie
Affiliations :
Department of Surgery, Tobata Kyoritsu Hospital, Kitakyusyu, Japan.
Department of Surgery, Kurume University School of Medicine, Kurume, Japan.
Publications dans "Oxygénation hyperbare" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Engineering, Tobata Kyoritsu Hospital, Kitakyusyu, Japan.
Publications dans "Oxygénation hyperbare" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Engineering, Tobata Kyoritsu Hospital, Kitakyusyu, Japan.
Publications dans "Oxygénation hyperbare" :
Diquafosol enhances fluid transfer and mucin secretion on ocular surface, which has been suggested as an effective treatment for dry eye disease (DED). The aim of the systematic review and meta-analys...
Relevant randomized controlled trials were obtained via search of electronic including PubMed, Embase, Cochrane Library, and Web of Science. A random-effects model was used to pool the results after i...
A total of nine RCTs involving 1295 patients with DED were included in the meta-analysis. Compared to treatment with 0.1% HA, topical treatment with 3% diquafosol significantly improved the Ocular Sur...
Topical treatment with 3% diquafosol may be more effective than 0.1% HA for patients with DED. However, the long-term efficacy and tolerability of diquafosol still need to be determined....
Narrowband ultraviolet B (NB-UVB) phototherapy is commonly prescribed for patients with moderate-to-severe atopic eczema (AE). The efficacy of NB-UVB, however, has not yet properly been established, a...
A pragmatic, multicenter, PROBE trial will be performed with 1:1 randomization of 316 adult patients with moderate-to-severe AE who have inadequate disease control with topical therapy and who are eli...
The UPDATE trial aims to provide high-quality evidence regarding the (cost-)effectiveness and safety of NB-UVB phototherapy in moderate-to-severe AE patients. Challenges that are addressed in the prot...
ClinicalTrials.gov NCT05704205. Registered on December 8, 2022....
Topical drugs are often used as first-line treatment for dermatological conditions. A within-person design may then be well adapted: it consists of randomizing lesions/body sites rather than patients,...
The aim of this review was to provide a methodological overview of within-person randomized trials (WP-RCTs) in dermatology....
We searched for eligible trials published between 2017 and 2021 in MEDLINE, Embase, and Central in dermatology journals and the 6 highest-impact-factor general medical journals. Two authors selected p...
From 1,034 articles identified, we included 54 WP-RCTs, mainly for acne vulgaris, psoriasis, actinic keratosis, and atopic dermatitis. In most of the trials, patients had only 2 lesions/body sites. In...
Our systematic review highlights that despite the publication of the CONSORT checklist extension for WP-RCTs in 2017, this design is rarely used, and when it is, there are methodological and reporting...
We aim to evaluate the clinical efficacy and safety of using laser and light combined with topical minoxidil for alopecia areata. We searched PubMed, Embase, Web of Science, the Cochrane Library, Chin...
Vulvar lichen sclerosus (LS) is a chronic debilitating inflammatory skin disease. Today, the gold standard is a life-long topical steroid treatment. Alternative options are highly desired. We present ...
We recruited 66 patients, 44 in the laser arm and 22 in the steroid arm. Patients with a physician-administered clinical LS score ≥ 4 were included. Participants received either four laser treatments ...
The findings of this trial have the potential to offer a novel treatment option for LS. The standardized Nd:YAG/Er:YAG laser settings and the treatment regime are presented in this paper....
NCT03926299....
Alopecia areata (AA) is a common autoimmune skin disease. Our study aimed to systematically evaluate the efficacy and safety of compound glycyrrhizin (CG) combined with topical minoxidil therapy in tr...
We searched the PubMed, EMBASE, Cochrane Library, Web of Science, CNKI, Wanfang, and VIP databases. Randomized controlled trials (RCTs) on CG combined with topical minoxidil therapy compared with topi...
11 RCTs and 1189 patients were included. Compared with topical minoxidil therapy alone, CG combined with topical minoxidil therapy was more effective at improving the clinical efficacy (RR = 1.36, 95%...
The current evidence indicates that CG combined with topical minoxidil therapy is effective and safe for AA. However, owing to the suboptimal quality of the included studies, more high-quality and lar...
The purpose was to identify and summarize the existing evidence on the efficacy and safety of the topical application of olive oil for preventing pressure ulcers (PUs). We included only randomized con...
To investigate the clinical efficacy and safety of topical difamilast in mild-to-moderate atopic dermatitis (AD)....
Only randomized controlled trials (RCTs) that compared topical difamilast with vehicle treatment for patients with AD were included. PubMed, Web of Science, Ovid Medline, Cochrane Library, ClinicalTri...
Five studies enrolling a total of 1009 patients with mild-to-moderate AD were identified. Compared with the topical vehicle, topical difamilast was associated with a significantly higher success rate ...
This meta-analysis suggests that topical difamilast is an effective and safe treatment for mild-to-moderate AD....
Melasma is a chronic relapsing skin condition. Laser therapy is a new advancement in treatment. Whether the topical application of tranexamic acid (TXA) increases the efficacy of laser therapy in mela...
Randomized controlled trials are used to estimate the causal effect of a treatment on a health outcome of interest in a patient population. Often the specified treatment in a randomized controlled tri...
We use causal reasoning to explain why randomized controlled trials of biomarker targets can arrive at conflicting or misleading conclusions. We describe four key threats to the validity of trials of ...
We illustrate these findings using evidence from 15 randomized controlled trials of blood pressure targets for management of hypertension. Randomized trials of blood pressure targets exhibit substanti...
Researchers should critically assess meta-analyses of trials of targets for variation in the types, distributions, and off-target effects of therapies studied. Trial investigators should release detai...